New Search

Refine your search within these categories:

1. Human Genes (group results)

2. Interaction: Human Genes and Chemicals (group results)

3. Bioactivity (group results)

4. Semantic Terms (group results)

A. Anatomy (group results)

B. Organisms

C01. Bacterial Infections and Mycoses (group results)

C02. Virus Diseases (group results)

C03. Parasitic Diseases (group results)

C04. Neoplasms (group results)

C05. Musculoskeletal Diseases (group results)

C06. Digestive System Diseases (group results)

C07. Stomatognathic Diseases (group results)

C08. Respiratory Tract Diseases (group results)

C09. Otorhinolaryngologic Diseases (group results)

C10. Nervous System Diseases (group results)

C11. Eye Diseases (group results)

C12. Male Urogenital Diseases (group results)

C13. Female Urogenital Diseases and Pregnancy Complications (group results)

C14. Cardiovascular Diseases (group results)

C15. Hemic and Lymphatic Diseases (group results)

C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results)

C17. Skin and Connective Tissue Diseases (group results)

C18. Nutritional and Metabolic Diseases (group results)

C19. Endocrine System Diseases (group results)

C20. Immune System Diseases (group results)

C21. Disorders of Environmental Origin (group results)

C22. Animal Diseases (group results)

C23. Pathological Conditions, Signs and Symptoms: all > Signs and Symptoms [MESH:D012816] > Neurologic Manifestations [MESH:D009461] > Dyskinesias [MESH:D020820] > Tremor [MESH:D014202]

C24. Occupational Diseases (group results)

C25. Chemically-Induced Disorders (group results)

C26. Wounds and Injuries (group results)

D01. Inorganic Chemicals (group results)

D02. Organic Chemicals (group results)

D03. Heterocyclic Compounds (group results)

D04. Polycyclic Compounds (group results)

D05. Macromolecular Substances (group results)

D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results)

D08. Enzymes and Coenzymes (group results)

D09. Carbohydrates (group results)

D10. Lipids (group results)

D12. Amino Acids, Peptides, and Proteins (group results)

D13. Nucleic Acids, Nucleotides, and Nucleosides (group results)

D20. Complex Mixtures (group results)

D23. Biological Factors (group results)

D25. Biomedical and Dental Materials (group results)

D26. Pharmaceutical Preparations (group results)

D27. Chemical Actions and Uses (group results)

E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results)

F. Psychiatry and Psychology (group results)

G. Phenomena and Processes (group results)

I. Anthropology, Education, Sociology and Social Phenomena

J. Technology, Industry, Agriculture (group results)

N. Health Care (group results)

Recently Viewed Items
 
These terms define your current search. Click the
×
to remove a term.

C23. Pathological Conditions, Signs and Symptoms: Signs and Symptoms [MESH:D012816] > Neurologic Manifestations [MESH:D009461] > Dyskinesias [MESH:D020820] > Tremor [MESH:D014202]
×

840 items, grouped by C23. Pathological Conditions, Signs and Symptoms (view ungrouped items)

Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25)   
MESH:C006780
 bisphenol A
C006780
 
  
  
  
MESH:C012606
 4-vinyl-1-cyclohexene dioxide
C012606
 
  
  
  
MESH:C014215
 tetrahydropalmatine
C014215
 
  
  
  
MESH:C015001
 arsenite
C015001
 
  
  
  
MESH:C016403
 2,4-dinitrotoluene
C016403
 
  
  
  
MESH:C079215
 3,5-dihydroxyphenylglycine
C079215
 
  
  
  
MESH:C089032
 rimonabant
C089032
 
  
  
  
MESH:C094503
 2-arachidonylglycerol
C094503
 
  
  
  
MESH:C121465
 6-methyl-2-(phenylethynyl)pyridine
C121465
 
  
  
  
MESH:C400082
 bortezomib
C400082
 
  
  
  
MESH:C564105
 Fragile X Tremor Ataxia Syndrome
C564105
 
  
  
  
MESH:D003513
 Cycloheximide
D003513
 
  
  
  
MESH:D004041
 Dietary Fats
D004041
 
  
  
  
MESH:D004221
 Disulfiram
D004221
 
  
  
  
MESH:D008731
 Methoxychlor
D008731
 
  
  
  
MESH:D008911
 Minocycline
D008911
 
  
  
  
MESH:D010672
 Phenytoin
D010672
 
  
  
  
MESH:D011794
 Quercetin
D011794
 
  
  
  
MESH:D013629
 Tamoxifen
D013629
 
  
  
  
MESH:D013749
 Tetrachlorodibenzodioxin
D013749
 
  
  
  
MESH:D013893
 Thiram
D013893
 
  
  
  
MESH:D015032
 Zinc
D015032
 
  
  
  
MESH:D019327
 Copper Sulfate
D019327
 
  
  
  
MESH:D020888
 Vigabatrin
D020888
 
  
  
  
MESH:D024483
 Vitamin K 3
D024483
 
  
  
  

Geniospasm [MESH:C537682] (1)   
MESH:C537682
 Geniospasm
C537682
 
  
  
  

Primary orthostatic tremor [MESH:C536418] (1)   
MESH:C536418
 Primary orthostatic tremor
C536418
 
  
  
  

Tremor hereditary essential, 2 [MESH:C536546] (1)   
MESH:C536546
 Tremor hereditary essential, 2
C536546
 
  
  
  

Tremor of Intention, Ataxia, and Lipofuscinosis [MESH:C566038] (1)   
MESH:C566038
 Tremor of Intention, Ataxia, and Lipofuscinosis
C566038
 
  
  
  

 (others) (811)   
MESH:C000541
 cyclopamine
C000541
 
  
  
  
MESH:C000912
 diazoxon
C000912
 
  
  
  
MESH:C001369
 HA 966
C001369
 
  
  
  
MESH:C001422
 4-hydroxypropranolol
C001422
 
  
  
  
MESH:C001451
 Innovar
C001451
 
  
  
  
MESH:C001470
 4-ipomeanol
C001470
 
  
  
  
all 811 items...